ESG A key driver to build business resilience

News

Pharma’s ESG goals need to underscore push for health equity

New data outlines the potential benefits for the pharmaceutical industry of reducing health disparities to meet its ESG goals.

Akosua Mireku

Analyst Comment

ESG – Healthcare: Macroeconomic trends

Analyst Comment

ESG – Top Trends in Healthcare: Technology trends

Features

ESG in clinicals trials: What pharma needs to know

News

Accountability of environmental, social, and governance (ESG) issues should lie with senior executives: Poll

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Pharma’s ESG goals need to underscore push for health equity

ESG – Healthcare: Macroeconomic trends

ESG – Top Trends in Healthcare: Technology trends

ESG in clinicals trials: What pharma needs to know

Accountability of environmental, social, and governance (ESG) issues should lie with senior executives: Poll

Leading lead generation providers and technology solutions for the pharmaceutical industry

Leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief